-
1
Efficacy and safety of sintilimab plus XELOX as a neoadjuvant regimen in patients with locally advanced gastric cancer: A single-arm, open-label, phase II trial
Published 2022-08-01Subjects: “…neoadjuvant regimen…”
Get full text
Article -
2
Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
Published 2022-05-01Subjects: Get full text
Article